2010
DOI: 10.1186/1756-0500-3-99
|View full text |Cite
|
Sign up to set email alerts
|

Two novel missense mutations in the myelin protein zero gene causes Charcot-Marie-Tooth type 2 and Déjérine-Sottas syndrome

Abstract: BackgroundThe Charcot-Marie-Tooth (CMT) phenotype caused by mutation in the myelin protein zero (MPZ) gene varies considerably, from early onset and severe forms to late onset and milder forms. The mechanism is not well understood. The myelin protein zero (P0) mediates adhesion in the spiral wraps of the Schwann cell's myelin sheath. The crystalline structure of the extracellular domain of the myelin protein zero (P0ex) is known, while the transmembrane and intracellular structure is unknown.FindingsOne novel … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Is there any other evidence that mutation at position x 94 is linked to disease and is affecting glycosylation? There are three new mutations associated with a peripheral neuropathy occurring in position x 94 : G 94 →C (Boerkoel et al, ) and the recently discovered mutations G 94 →S and G 94 →D (Braathen et al, ); neither of these recently discovered mutations has yet been deposited (June, 2014) in the database http://www.uniprot.org/uniprot/P25189. Glycosylation has not been investigated in functional studies, the NetNGlyc 1.0 Server predicts that glycosylation is not prohibited for G 94 →C and may not occur in mutations G 94 →S and G 94 →D (Braathen et al, ).…”
Section: Loss and Gain Of Glycosylation In P0 Human Protein From Poinmentioning
confidence: 99%
“…Is there any other evidence that mutation at position x 94 is linked to disease and is affecting glycosylation? There are three new mutations associated with a peripheral neuropathy occurring in position x 94 : G 94 →C (Boerkoel et al, ) and the recently discovered mutations G 94 →S and G 94 →D (Braathen et al, ); neither of these recently discovered mutations has yet been deposited (June, 2014) in the database http://www.uniprot.org/uniprot/P25189. Glycosylation has not been investigated in functional studies, the NetNGlyc 1.0 Server predicts that glycosylation is not prohibited for G 94 →C and may not occur in mutations G 94 →S and G 94 →D (Braathen et al, ).…”
Section: Loss and Gain Of Glycosylation In P0 Human Protein From Poinmentioning
confidence: 99%
“…Mutations in the myelin protein zero (MPZ) gene cause hereditary, autosomal dominant demyelinating sensorimotor polyneuropathy Charcot-Marie-Tooth (CMT) 1B [1], late-onset, mixed demyelinating and axonal polyneuropathy [2,3]. late-onset autosomal dominant, axonal sensorimotor polyneuropathy CMT 2I/J [3,4], early-onset Dejerine-Sottas syndrome [5], or congenital hypomyelinating polyneuropathy [6,7,8,9]. Though MPZ-mutations have been reported to cause deafness [10,11,12] and may go along with elevated creatine-kinase (CK) [13], the association of an MPZ-mutation with early-onset demyelinating neuropathy, hypoacusis and neuropathological features of inclusion-body-myopathy (IBM), as in the following case, has not been reported.…”
Section: Introductionmentioning
confidence: 99%